CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 220 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 4.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $6,891,000 | -13.3% | 438,342 | -0.4% | 0.08% | -21.9% |
Q4 2017 | $7,952,000 | +184.0% | 440,300 | +203.4% | 0.10% | +182.4% |
Q3 2017 | $2,800,000 | +328.1% | 145,100 | +161.9% | 0.03% | +277.8% |
Q2 2017 | $654,000 | +7.7% | 55,400 | 0.0% | 0.01% | +12.5% |
Q1 2017 | $607,000 | +87.3% | 55,400 | +24.2% | 0.01% | +60.0% |
Q4 2016 | $324,000 | +489.1% | 44,600 | +424.7% | 0.01% | +400.0% |
Q3 2016 | $55,000 | – | 8,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |